"Smaller players will likely need to demonstrate either superior tolerability, novel indication-specific efficacy, meaningfully different dosing convenience, or combination strategies that address limitations of current agents, particularly muscle loss, rather than simply competing on weight-loss magnitude alone," says Nadolsky
Eryptosis in patients with chronic kidney disease: a possible relationship with oxidative stress and inflammatory markers
BMC Musculoskelet Disord 20:605
What are your questions about GLP-1 medications
If youre sensitive to caffeine, especially while using GLP-1, you may want to choose decaffeinated or herbal varieties later in the day
Consistent receptor activation means consistent appetite suppression and metabolic effects throughout the week